Arizona Qualifying Conditions: Detailed Guide
Qualifying Medical Conditions for Medical Marijuana in Arizona
Arizona's medical marijuana program recognizes specific qualifying conditions as defined by state law. Below is an overview of Arizona's program, including the official list of qualifying conditions, eligibility criteria, and program details.
Established by Proposition 203 in 2010, Arizona's medical marijuana program is administered by the Arizona Department of Health Services (ADHS). The program allows patients with qualifying conditions to obtain a medical marijuana card.### Official Qualifying Conditions (ARS 36-2801)
Per Arizona Revised Statutes Section 36-2801, a "debilitating medical condition" means one or more of the following:
Named Conditions:
-
HIV/AIDS (Positive status for human immunodeficiency virus or acquired immune deficiency syndrome)
-
Amyotrophic Lateral Sclerosis (ALS)
-
Alzheimer's Disease (specifically agitation of Alzheimer's disease)
-
Post-Traumatic Stress Disorder (PTSD) (added by the Department)
Conditions Causing These Symptoms:
Any chronic or debilitating disease or medical condition (or its treatment) that produces:
-
Seizures (including those characteristic of epilepsy)
-
Severe and Persistent Muscle Spasms (including those characteristic of multiple sclerosis)
About the Qualifying Medical Conditions
Below is information about each qualifying condition and the research that informed Arizona's decision to include it in the state program.
Cancer
Cancer is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on research examining cannabinoid use among cancer patients experiencing treatment-related symptoms.
Glaucoma
Glaucoma is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on early research examining the relationship between cannabinoids and intraocular pressure.
HIV/AIDS
HIV/AIDS is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on research examining cannabinoid use among HIV/AIDS patients experiencing appetite and weight-related concerns.
Hepatitis C
Hepatitis C is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on research examining cannabis use among patients undergoing antiviral treatment regimens.
Amyotrophic Lateral Sclerosis (ALS)
ALS is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on research surveying ALS patients about symptom management approaches.
Crohn's Disease
Crohn's Disease is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on clinical research examining cannabis use in patients with Crohn's Disease.
Alzheimer's Disease (Agitation)
Agitation associated with Alzheimer's Disease is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on research examining cannabinoid use among Alzheimer's patients experiencing behavioral symptoms.
Post-Traumatic Stress Disorder (PTSD)
PTSD is an approved qualifying condition under Arizona's medical marijuana program, added by the Arizona Department of Health Services. Arizona included this condition based on research examining cannabinoid use among patients with PTSD.
Cachexia (Wasting Syndrome)
Cachexia or Wasting Syndrome is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on research examining dronabinol (synthetic THC) use in patients experiencing appetite and weight loss concerns.
Severe and Chronic Pain
Severe and Chronic Pain is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on systematic reviews examining cannabinoid use among patients with chronic pain conditions.
Severe Nausea
Severe Nausea is an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on research examining cannabinoid use among patients experiencing nausea, including chemotherapy-induced nausea.
Seizures (Including Epilepsy)
Seizures, including those characteristic of epilepsy, are an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on clinical trial research examining CBD in patients with treatment-resistant epilepsy.
Severe or Persistent Muscle Spasms (Including MS)
Severe or persistent muscle spasms, including those characteristic of multiple sclerosis, are an approved qualifying condition under Arizona's medical marijuana program per ARS 36-2801. Arizona included this condition based on clinical research examining cannabinoid use in patients with MS-related spasticity.
Important Program Details
-
Card Validity: 2 years
-
State Fee: $150 (reduced for SNAP/SSI recipients)
-
Telehealth: Fully available for initial evaluations and renewals
-
Age: 18+ (minors require designated caregiver and additional physician certification)